Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$542.50 -6.54 (-1.19%)
At close: Nov 5, 2026 · 4:00 PM EST

Vertex Pharmaceuticals (VRTX) Convertible Debt (2010 - 2013)

Updated

Vertex Pharmaceuticals (VRTX) recorded Convertible Debt of $400 million in Q1 2013, unchanged from $400 million a year earlier and unchanged from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Convertible Debt (2010 - 2013) Analysis & Trends

Starting with Q1 2010, Vertex Pharmaceuticals' Convertible Debt history includes 12 quarters.

  • Across earlier years, Convertible Debt came in at $400 million in FY2011 (unchanged) and $400 million in FY2010.
  • Per Business Quant, the preceding three quarters came in at $400 million (Q4 2012), $400 million (Q3 2012) and $400 million (Q2 2012).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn
5 Novartis Ag 313.89 Bn 287.12 Bn -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn
10 Vertex Pharmaceuticals 137.20 Bn 109.19 Bn 2.91 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2013 400.00 Mn
Dec 31, 2012 400.00 Mn
Sep 30, 2012 400.00 Mn
Jun 30, 2012 400.00 Mn
Mar 31, 2012 400.00 Mn
Dec 31, 2011 400.00 Mn
Sep 30, 2011 400.00 Mn
Jun 30, 2011 400.00 Mn
Mar 31, 2011 400.00 Mn
Dec 31, 2010 400.00 Mn
Sep 30, 2010 400.00 Mn
Mar 31, 2010 32.10 Mn
API Access

Vertex Pharmaceuticals Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=VRTX&period=max&api_key=YOUR_API_KEY